Although benign tumors predominantly displayed nuclear localization of Rb2/p130, BOTs showed both nuclear and cytoplasmic expression patterns; moreover, malignant tumors primarily exhibited cytoplasmic expression. Here, RBL2 is linked to benign neoplasm.